Rheinmetall's Billion-Euro UK Order and New Artillery Plant Can't Mask Market Doubts Over Defense Budget Shift

Rheinmetall shares hit 52-week lows amid analyst shift from artillery to drones, despite €1B UK training deal and strong production output.

The pressure on Rheinmetall's stock shows no sign of letting up. The shares closed at €965 on Wednesday, leaving them just 6.9% above a 52-week low of €902.50 hit in late June and a staggering 51.7% below last September's all-time high of €1,995. The year-to-date loss now stands at 39.7%, and the Relative Strength Index at 34.8 signals the stock is deeply oversold. With a market capitalisation of €45.6 billion, the defence group finds itself squeezed between an extraordinary pipeline of contracts and a growing analyst conviction that the era of artillery-led warfare is fading.

News of a near-billion-euro training contract from the British army briefly pushed the shares higher, but the gains evaporated almost as quickly as they appeared. Rheinmetall Electronics UK, as part of the Omnia Training Consortium led by Raytheon UK, will deliver live, virtual and constructive simulation systems under a 15-year service agreement starting in summer 2026. The deal, valued at roughly €1 billion for Rheinmetall's share, is a clear vote of confidence in the company's ability to support modern armed forces. Yet investors were left guessing whether the revenue was already baked into management's 2026 guidance — the company has forecast sales of up to €14.5 billion that year, representing 40-45% growth. The uncertainty prevented the stock from reclaiming the €1,000 mark and instead it ended the session down 0.7% at €968.

The deeper drag on the share price stems from a decisive shift in how defence analysts view the future of land warfare. Bank of America's Benjamin Heelan slashed his price target from €1,770 to €1,300, cutting his 2030 revenue projection for Rheinmetall from €50 billion to €35 billion. His reasoning: national defence budgets are pivoting away from artillery and towards air defence, drones and precision systems. Heelan reduced his estimate for the weapons and ammunition division from €14-16 billion to €10 billion, still assuming a healthy 24% margin, and criticised the portfolio as too reliant on legacy munitions. The downgrade landed particularly hard because it struck at the heart of Rheinmetall's growth narrative — a narrative that had previously justified a stock price almost double the current level.

None of this means the company's factories are idle. Rheinmetall recently delivered the first batch of 155mm RH1412 artillery rounds from its new plant in Unterlüß, Lower Saxony, to Ukraine. The shells have a range of up to 40 kilometres and are compatible with the PzH 2000, CAESAR and Bogdana systems. A low five-figure number of rounds are being supplied, financed by a NATO country in a low double-digit million euro contract. More than half has already been handed over, with the remainder due by the end of 2026. The plant, which cost €500 million to build and opened in August 2025, is targeting an annual capacity of 350,000 rounds by 2027. The group-wide goal is 1.5 million shells a year by 2030. Additionally, Rheinmetall won a contract from Kuwait for MASS decoy systems for eight ships, with deliveries spread from mid-2026 to mid-2029, and was awarded leadership of the Bundeswehr's InterRoC VII research project.

Yet even as the order book swells to a record €73 billion — up 31% year-on-year — the stock has failed to find a floor. Additional headwinds have piled up. Berenberg and JPMorgan both lowered their price targets following the cancellation of the F126 frigate programme, though they maintained broadly positive ratings. The stock now trades 35.7% below its 200-day moving average of €1,506, and its annualised volatility stands at nearly 69%, underscoring investor nervousness. Rheinmetall has also started to branch out beyond core defence: a pilot project for teleoperated shuttles at Düsseldorf Airport began on 13 July 2026, hinting at a longer-term diversification strategy. But for now, the market's message is clear — operational wins are not enough when the long-term thesis is under question. Whether the balance tips back towards the company's massive backlog or continues to track the bearish analyst narrative will determine if the stock can bounce from its near-low, or sink further still.